INO-transit: inotuzumab ozogamicin treatment prior to chimeric antigen receptor T-cell therapy in relapsed/refractory B-cell acute lymphoblastic leukemia: real-world patient characteristics and outcomes in Spain, the UK and US
Martinez-Cibrian, N. Ortiz-Maldonado, V. Goñi, C. B. Suñol, P. B. Calvo, M. C. Cassaday, R. D. George, L. Kwon, M. Murthy, G. S. G. Nicholson, E.
Martinez-Cibrian, N.
Ortiz-Maldonado, V.
Goñi, C. B.
Suñol, P. B.
Calvo, M. C.
Cassaday, R. D.
George, L.
Kwon, M.
Murthy, G. S. G.
Nicholson, E.
Abstract
Authors
Martinez-Cibrian, N.
Ortiz-Maldonado, V.
Goñi, C. B.
Suñol, P. B.
Calvo, M. C.
Cassaday, R. D.
George, L.
Kwon, M.
Murthy, G. S. G.
Nicholson, E.
Richardson, D.
Schwartz, M.
Wallis, H.
Dorman, S.
Pulido, S.
Reeves, E.
Jiang, W.
Amet, M.
Rajkovic-Potjewyd, I.
Reynolds, N.
Russell-Smith, A.
Marks, D.
Castleton, A.
Ortiz-Maldonado, V.
Goñi, C. B.
Suñol, P. B.
Calvo, M. C.
Cassaday, R. D.
George, L.
Kwon, M.
Murthy, G. S. G.
Nicholson, E.
Richardson, D.
Schwartz, M.
Wallis, H.
Dorman, S.
Pulido, S.
Reeves, E.
Jiang, W.
Amet, M.
Rajkovic-Potjewyd, I.
Reynolds, N.
Russell-Smith, A.
Marks, D.
Castleton, A.
Description
Date
2025
Publisher
Collections
Keywords
Type
Article
Citation
Martinez-Cibrian N, Ortiz-Maldonado V, Goñi CB, Suñol PB, Calvo MC, Cassaday RD, et al. INO-transit: inotuzumab ozogamicin treatment prior to chimeric antigen receptor T-cell therapy in relapsed/refractory B-cell acute lymphoblastic leukemia: real-world patient characteristics and outcomes in Spain, the UK and US. Blood. 2025 NOV 3;146:2369-70.